Profile data is unavailable for this security.
About the company
Curasight A/S is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). The technology provides improved diagnosis and risk stratification in multiple cancer types.
- Revenue in DKK (TTM)-44.69m
- Net income in DKK-48.25m
- Incorporated2013
- Employees4.00
- LocationCurasight A/SOle Maaloees Vej 3, Koebenhavn NKOEBENHAVN 2200DenmarkDNK
- Websitehttps://www.curasight.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Herantis Pharma Oyj | 0.00 | -40.74m | 378.05m | 13.00 | -- | 28.93 | -- | -- | -0.2417 | -0.2417 | 0.00 | 0.0726 | 0.00 | -- | -- | 0.00 | -124.50 | -81.63 | -166.61 | -107.95 | -- | -- | -- | -- | -- | -17.91 | 0.6101 | -- | -- | -- | -1,865.03 | -- | -- | -- |
| Lytix Biopharma AS | 248.68k | -48.30m | 485.22m | 6.00 | -- | 8.16 | -- | 1,951.18 | -1.08 | -1.08 | 0.0055 | 1.15 | 0.005 | -- | 0.0579 | 62,833.33 | -96.51 | -61.17 | -123.25 | -71.49 | -- | -- | -19,422.02 | -722.29 | -- | -- | 0.0301 | -- | 178.98 | 104.67 | -7.24 | -- | -- | -- |
| Hamlet BioPharma AB | 0.00 | -39.96m | 493.48m | 6.00 | -- | 17.32 | -- | -- | -0.3157 | -0.3157 | 0.00 | 0.2927 | 0.00 | -- | -- | 0.00 | -95.68 | -78.53 | -104.48 | -91.76 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -30.70 | -- | -- | -- |
| Nanoform Finland Oyj | 22.08m | -162.68m | 502.46m | 173.00 | -- | 1.51 | -- | 22.75 | -0.2613 | -0.2613 | 0.0354 | 0.5203 | 0.0442 | 80.07 | 9.22 | 16,328.73 | -32.55 | -26.72 | -36.27 | -29.06 | -441.87 | -539.46 | -736.69 | -918.61 | 4.30 | -- | 0.1281 | -- | 8.22 | 124.15 | -12.87 | -- | -1.62 | -- |
| Oncopeptides AB | 44.23m | -189.30m | 517.16m | 75.00 | -- | 111.77 | -- | 11.69 | -1.20 | -1.20 | 0.2798 | 0.0253 | 0.2359 | 0.2049 | 1.79 | 782,225.00 | -100.98 | -148.24 | -125.09 | -215.27 | 97.88 | -- | -428.01 | -2,013.60 | 3.27 | -12.10 | 0.9507 | -- | -10.14 | -- | -14.25 | -- | -7.14 | -- |
| Curasight A/S | -44.69m | -48.25m | 699.48m | 4.00 | -- | 40.04 | -- | -- | -1.13 | -1.13 | -1.07 | 0.3809 | -1.52 | -- | -- | -11,171,250.00 | -163.63 | -37.34 | -313.58 | -40.89 | -- | -- | -- | -- | -- | -16.54 | 0.00 | -- | -27.21 | -- | -40.76 | -- | -- | -- |
| XSpray Pharma AB (publ) | 0.00 | -152.96m | 710.99m | 26.00 | -- | 1.57 | -- | -- | -5.96 | -5.96 | 0.00 | 15.37 | 0.00 | -- | -- | 0.00 | -29.09 | -23.48 | -30.93 | -25.08 | -- | -- | -- | -- | 5.93 | -18.44 | 0.1883 | -- | -- | -- | -58.92 | -- | -14.46 | -- |
| Nykode Therapeutics ASA | 42.47m | -68.99m | 778.56m | 62.00 | -- | 1.25 | -- | 18.33 | -0.3102 | -0.3102 | 0.1945 | 2.89 | 0.0494 | -- | 1.91 | 463,170.70 | -8.03 | 2.32 | -8.66 | 2.60 | -- | -- | -162.46 | 8.51 | -- | -- | 0.0284 | -- | -32.73 | -- | -10.43 | -- | -1.35 | -- |
| Cantargia AB | 218.17m | 98.89m | 908.41m | 23.00 | 10.20 | 4.32 | 8.96 | 4.16 | 0.5068 | 0.5068 | 1.33 | 1.20 | 1.41 | -- | 164.02 | 14,031,360.00 | 63.91 | -56.56 | 80.65 | -63.93 | -- | -- | 45.33 | -- | -- | 76.55 | 0.00 | -- | -- | -- | 42.27 | -- | -- | -- |
| Nightingale Health Oyj | 35.06m | -137.93m | 1.03bn | 100.00 | -- | 1.58 | -- | 29.41 | -0.3052 | -0.3052 | 0.0778 | 1.10 | 0.0568 | 0.9444 | 2.79 | 46,930.00 | -22.33 | -15.66 | -24.26 | -16.95 | 75.39 | 75.21 | -393.39 | -447.17 | 8.52 | -- | 0.0511 | -- | 7.69 | 21.38 | -5.71 | -- | -12.69 | -- |
| Solar Foods Oyj | 142.78k | -79.68m | 1.04bn | 57.00 | -- | 6.56 | -- | 7,302.83 | -0.433 | -0.433 | 0.0008 | 0.7115 | 0.0004 | -- | 0.0037 | 455.00 | -22.45 | -- | -27.05 | -- | 25,931.57 | -- | -55,808.37 | -- | -- | -7.03 | 0.5092 | -- | 275.15 | -- | -22.57 | -- | -- | -- |
Data as of Feb 11 2026. Currency figures normalised to Curasight A/S's reporting currency: Danish Krone DKK
